Omnicell is trading at $39.33, up +10.43%, amid a broad U.S. market relief rally after Democrats won control of both congressional chambers. - Investors welcomed greater certainty and the prospect of legislative gridlock. - Healthcare shares advanced on expectations of more favorable policy prospects, including possible support for Medicaid and ACA enrollment. - Reuters reported gains among health insurers and hospital operators; no Omnicell-specific announcement explaining the move surfaced in the search.